PeopleBio, Inc. (KOSDAQ: 304840)

Market Cap	62.45B
Revenue (ttm)	4.37B
Net Income (ttm)	-12.31B
Shares Out	21.17M
EPS (ttm)	-574.23
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	64,659
Average Volume	87,731
Open	3,050.00
Previous Close	2,985.00
Day's Range	2,950.00 - 3,050.00
52-Week Range	2,590.00 - 6,090.00
Beta	0.64
RSI	38.24
Earnings Date	Mar 18, 2025

About PeopleBio

PeopleBio, Inc., a biotech company, develops bioproducts for diagnostic and treatment of protein misfolding diseases. Its Multimer Detection System technology uses capturing antibodies and epitope-overlapping detection antibodies for the detection of oligomers or multimers from monomers in protein-misfolding diseases. PeopleBio, Inc. was founded in 2002 and is based in Seongnam, South Korea.

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 2002
• Employees: 66
• Stock Exchange: KOSDAQ
• Ticker Symbol: 304840

Financial Performance

In 2023, PeopleBio's revenue was 4.45 billion, an increase of 0.18% compared to the previous year's 4.44 billion. Losses were -16.03 billion, 12.1% more than in 2022.